NSEGeneral Updates31 Jul 2026 · 31 Jul 2026, 05:49 pm

General Updates

Medplus Health Services Limited · MEDPLUS

✦ AI Summary▼ NegativeRegulatory

MedPlus Health Services Limited has received a suspension order for a Drug License of a store situated in the state of Telangana, resulting in a potential revenue loss of Rs 2.34 lacs.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment3/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

MEDPLUS_31072026174850_Intimation.pdf

pdf

Download →
View document text
MedPlus Health Services Limited July 31, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received one suspension order for a Drug License of a store situated in the state of Telangana: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Nature and details of the Date of receipt of Details of the Impact on Authority action(s) taken, initiated direction or order, violation(s)/ financial or order(s) passed including any contravention(s) operation or interim or interim committed or other activities of orders, or any alleged to be the listed entity, other committed quantifiable in communication monetary terms from the to the extent authority possible Assistant Director, Drugs Suspension of Drug License Order received on Under Rule 65 of Potential Revenue Control Administration, for five days of store 30.07.2026 Drugs and Cosmetics Loss of Rs 2.34 Warangal, Telangana situated at SBH Colony Act, 1940 and Drugs lacs. Hanamkonda, Telangana and Cosmetics Rules, 1945 The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer (M. No. F12400) 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com